This multicenter, observational, study will enroll severe neurologically injured patients both prospectively and retrospectively. The aims are to identify the percent of neurocritical care patients with sodium levels ≤ 135 mEq/L, describe treatment strategies employed, determine the correlation of clinical factors (i.e. GCS, ICP) with serum sodium concentrations in patients prior to sodium altering therapy, and evaluate outcomes through evaluation of length of stay, discharge disposition, and modified Rankin score (mRS).
Study Type
OBSERVATIONAL
Enrollment
400
Hartford Hospital
Hartford, Connecticut, United States
Yale-New Haven Hospital
New Haven, Connecticut, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Jackson Memorial Hospital
Miami, Florida, United States
Memorial University Medical Center
Savannah, Georgia, United States
University of Chicago
Chicago, Illinois, United States
Via Christi Hospital
Wichita, Kansas, United States
UK Healthcare
Lexington, Kentucky, United States
The Johns Hopkins hospital
Baltimore, Maryland, United States
Detroit Receiving Hospital
Detroit, Michigan, United States
Spectrum Health
Grand Rapids, Michigan, United States
...and 7 more locations